pT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd's local peritoneal involvement revisited-Reference-Cited by-同舟云学术

pT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd's local peritoneal involvement revisited

Published:2014-01-10 Issue:2 Volume:135 Page:467-478
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Snaebjornsson P.¹²,Coupe V.M.H.³,Jonasson L.²⁴,Meijer G.A.¹,van Grieken N.C.¹,Jonasson J.G.²⁴⁵

Affiliation:

1. Department of Pathology; VU University Medical Center; Amsterdam The Netherlands

2. Department of Pathology; Landspitali-University Hospital; Reykjavik Iceland

3. Department of Epidemiology and Biostatistics; VU University Medical Center; Amsterdam The Netherlands

4. Faculty of Medicine; University of Iceland; Reykjavik Iceland

5. Icelandic Cancer Registry; Icelandic Cancer Society; Reykjavik Iceland

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. Revised TN categorization for colon cancer based on national survival outcomes data;Gunderson;J Clin Oncol,2010

2. College of American Pathologists Conference XXXV: solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation;Hammond;Arch Pathol Lab Med,2000

3. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features;O'Connor;J Clin Oncol,2011

4. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999;Compton;Arch Pathol Lab Med,2000

5. An evaluation of the relationship between lymph node number and staging in pT3 colon cancer using population-based data;Baxter;Dis Colon Rectum,2010

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to: Unveiling controversies: The role of HIPEC in colorectal cancer peritoneal metastasis;European Journal of Surgical Oncology;2024-06

2. Prognostic implications of T stage in different pathological types of colorectal cancer: an observational study using SEER population-based data;BMJ Open;2024-02

3. Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer;Therapeutic Advances in Medical Oncology;2024-01

4. Current Challenges and Controversies in Colorectal Carcinoma Pathologic Staging—A Practical Guide;Advances in Anatomic Pathology;2023-08-09

5. Efficacy and Safety of Intraoperative Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Colon Cancer;JAMA Surgery;2023-07-01